RxDoctor Payments Data

Diana Girnita

Rheumatology · Sunnyvale, CANPI 1922378116

Payments from drug & device makers

$44,253in general payments, 2019–2025

Across 182 payments — averaging $243.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$30K
  • UCB, Inc.$8K
  • UCB SA$4K
  • AbbVie$579
  • Lilly USA, LLC$312
  • Pfizer$217
  • plus $746 from 7 others

What the payments were for

  • Consulting fees$38,89088%
  • Travel & lodging$2,6986%
  • Food & beverage$2,6576%
  • Education$70%

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)30$30,441
UCB, Inc.16$7,629
UCB SA1$4,330
AbbVie38$579
Lilly USA, LLC31$312
Pfizer17$217
Johnson & Johnson17$153
Sanofi1$137
Regeneron Healthcare Solutions, Inc.8$133
E.r. Squibb & Sons, L.L.C.9$124
Novartis8$111
GSK5$73
Bristol Myers Squibb1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,253 in reported general payments places this provider in the 80th percentile of 808 rheumatology providers in California.

See all rheumatology providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisone21$218

Paid to pharmacies, not to this prescriber.

Other rheumatology in Sunnyvale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →